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1. INTRODUCTION 
Insulin resistance and chronic inflammation are 
implicated in the pathogenesis of type 2 diabetes (T2D) 
and in diabetic retinopathy (DR), its most prevalent 
ABSTRACT: Retinal diseases linked to inflammation, 
including diabetic retinopathy (DR), are often 
accompanied by resident macrophage/microglial cells 
activation. During DR, there are substantial changes in 
the polarization status of the microglia from the M2 
(anti-inflammatory) to the M1 (pro-inflammatory) stage. 
However, the dynamics between M1 and M2 
polarization of microglia during DR has not been 
investigated and it might be therapeutically useful. In 
this study, we have characterized the evolution of 
microglia polarizarion during the early stages of DR in 
the retina of diabetic db/db mice. Moreover, we have 
analyzed microglia polarization in response to pro-
(bacterial lipopolysaccharide; LPS) or anti-(IL4/IL13 
cytokines or the bicyclic nojirimycin derivative (1R)-1-
dodecylsulfinyl-5N,6O-oxomethylidenenojirimycin (R-
DS-ONJ)) inflammatory stimuli.  For this goal, we have 
performed in vitro experiments in Bv-2 murine 
microglial cells as well as ex vivo experiments in retinal 
explants from db/db mice. Treatment of Bv-2 cells with 
LPS together with IL4/IL13 or R-DS-ONJ switched the 
M1 response towards M2.  In retinal explants from 
db/db mice, R-DS-ONJ induced a M2 response. In 
conclusion, the modulation of microglia polarization 
dynamics towards a M2 status at early stages of DR 
offers novel therapeutic interventions. 
RESUMEN: Las enfermedades retinianas, entre las que 
se encuentra la retinopatía diabética (RD), están 
vinculadas a un contexto inflamatorio en el cual existe 
una activación de los macrófagos residentes en la retina 
(microglia). Durante la retinopatía diabética se producen 
cambios de polarización de la microglia, definiéndose 
éstos como transiciones entre el estado M1 (pro-
inflamatorio) y el estado M2 (anti-inflamatorio), estando 
aún por determinar los tiempos de aparición y actuación 
de la microglia en cada uno de ellos. La identificación 
espacio-temporal de la transición de la microglía de un 
estado a otro podría constituir una potente herramienta 
clínica para diferentes abordajes terapéuticos.  En este 
trabajo se ha caracterizado el estado de polarización de 
la microgía en la retina durante las primeras fases de la 
RD en el modelo de ratón diabético db/db. Además,  se 
ha estudiado  la polarización de la microglia en 
presencia de estímulos pro-inflamatorios 
(lipopolisacárido bacteriano; LPS) o anti-inflamatorios 
(citoquinas IL4/IL13 o un compuesto natural derivado 
de la casternospermina, R-DS-ONJ). Para ello, se ha 
realizado un abordaje in vitro utilizando la línea celular 
de microglia murina Bv-2 y un abordaje ex vivo con 
explantes de retinas procedentes de ratones diabéticos 
db/db. El tratamiento de las células Bv-2 con LPS en 
combinación con IL4/IL13  o alternativamente con el 
compuesto R-DS-ONJ indujo la transición en la 
polarización de la microglia desde el estado pro-
inflamatorio M1, inducido por el LPS, al estado anti-
inflamatorio M2. En los explantes de retinas de ratones 
db/db, el compuesto R-DS-ONJ indujo la respuesta M2 
disminuyendo la respuesta M1. En conclusión, la 
polarización de la microglia hacía un estado M2 durante 
los estadíos tempranos de la RD ofrece una nueva 
ventana terapéutica de actuación. 
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complication (1). In fact, neuroinflammation induced by 
the diabetic milieu is a central contributing factor in DR 
progression (2). Similarly to other neurodegenerative 
diseases, DR exhibits characteristics of low-grade chronic 
inflammation (3) in which changes in retinal expression of 
inflammatory mediators occur in concert with functional 
changes in retinal permeability and apoptosis (4, 5). It has 
been proposed that in neuroinflammation microglia 
becomes activated and produce inflammatory mediators. 
Microglia, serving as resident macrophages of the retina, 
has multiple functional states and carries out diverse 
functions. Capable of rapid dynamism and motility, 
microglial cells synthesize and release cytokines, 
chemokines, neurotrophic factors, and neurotransmitters 
that interact with multiple cell types in the central nervous 
system (CNS) and exert cytotoxic, cytoprotective and 
scavenger effects depending on the tissue context (6). 
Retinal diseases such as proliferative DR and diabetic 
macular edema are often accompanied by 
macrophage/microglia cells activation (7, 8). 
    The existence of a continuum of polarization states 
in macrophages results from the integration of the 
intracellular signals triggered by their surrounding milieu 
(9, 10). M1, or classically-activated macrophages, mainly 
secrete pro-inflammatory cytokines such as TNFα, IL12, 
IL23, IL1β, IL6 and chemotactic factors and are involved 
in the pro-inflammatory response. By contrast, 
alternatively-activated macrophages (M2) express high 
levels of arginase-1 and IL10, but low levels of IL12 and 
IL23 and are usually induced by the anti-inflammatory 
cytokines IL4 and IL13 (11).  
DR exhibits many features of chronic inflammation 
such as increased NO production and release of pro-
inflammatory cytokines (12). In fact, TNFα, IL1β, IL-8 
and MCP-1 have been found elevated in the vitreous of 
diabetic patients (13, 14). Recently, the inflammasome 
complex, which cleaves pro-IL1β into secreted IL1β via 
caspase-1, has been found activated in retinal pigment 
epithelial cells cultured under high glucose levels (15), but 
its modulation in the retina during DR has not yet been 
explored. In this scenario, microglia may underline its 
different functional properties and, therefore, targeting its 
polarization is a promising approach for the treatment of 
CNS diseases (16) including DR.  
Among therapies targeting pro-inflammatory 
mediators, the natural compounds have emerged as an 
alternative to chemical drugs. Iminosugar glycosyl 
hydrolase inhibitors such as 1-deoxynojirimycin and 
castanospermine have a strong potential in therapies for 
cancer, viral infections, diabetes and glycosphingolipid 
storage disorders (17, 18). In particular, sp2-iminosugar-
type bicyclic nojirimycin analogues with an alpha-
configured N-, S-, or C-linked pseudoanomeric group have 
been previously evaluated as antitumor agents (18). 
However, their effects in inflammatory processes during 
DR remain to be elucidated.  
In recent years the C57BL/KsJ-db/db mouse model has 
been extensively used to investigate the pathogenesis of 
DR (19) since reproduce the neurodegenerative process 
that occur in the human diabetic retina (20). However, the 
events that occur in the retina at early stages of DR 
previous to neurodegeneration, and, in particular the role 
of microglia associated to neuroinflammation in db/db 
mice remain unknown. The aim of this study is to examine 
the polarization of microglia during the early stages of DR 
and its modulation by a sp2-iminosugar-type bicyclic 
nojirimycin analogue. 
2. METHODS 
2.1. Reagents and drugs 
Fetal bovine serum (FBS) and culture media were 
obtained from Invitrogen (Grand Island, NY, USA). 
Bovine serum albumin (BSA) and bacterial 
lipopolysaccharide (LPS) were purchased from Sigma-
Aldrich (St Louis, MO, USA). IL4 and IL13 were 
purchased from Preprotech (London, UK). Bradford 
reagent, acrylamide, immunoblot PVDF membranes and 
chemioluminiscent HRP Substrate were purchased from 
Bio-Rad (Madrid, Spain). 
2.2. Cell culture  
Mouse microglia Bv-2 cell line was provided by Dr. 
M.L. Nieto (CSIC, Spain). Bv-2 cells were cultured at 
37°C in a humidified atmosphere with 5 % CO2 in RPMI 
supplemented with 10 % (v/v) heat-inactivated FBS, 1 % 
(v/v) penicillin/streptomycin (Sigma) and 2 mM L-
glutamine (Gibco, Carlsbad, California, USA). Cells were 
grown up to 70 % confluence, washed with PBS and 
further stimulated in serum-free medium with LPS (200 
ng/ml) with or without a mixture of  IL4/IL13 (20 ng/ml 
each; M2) or R-DS-ONJ (compound C5) for several time-
periods. For mouse cell line authentication, genomic DNA 
was isolated from Bv-2 cells and analyzed by PCR as 
described (21). Primer sequences used for amplification of 
mouse STR were: Forward (6-7) 
5´AGTCCACCCAGTGCATTCTC 3´; Reverse (6-7) 
5´CATGTGGCTGGTATGCTGTT 3´; Forward (15-3) 5´ 
TCTGGGCGTGTCTGTCATAA 3´: Reverse (15-3) 5´ 
TTCTCAGGGAGGAGTGTGCT 3´. 
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Figure 1. Murine Cell line authentication. Bv.2 murine microglia cell line was authenticated at IIBM Genomic Core Facility. HS: 
Homo sapiens control DNA; Mm: Mus musculus control DNA. 
2.3. Animals and retina isolation 
C57BL/KsJ db/db and db/+ male mice were purchased 
from Harlan (Harlan Laboratories, Inc. UK). Mice were 
maintained in light/dark (12-hours light/12-hours dark)-, 
temperature (22°C)- and humidity-controlled rooms, and 
fed ad libitum with free access to water. All animal 
experimentation followed recommendations of the 
Federation of European Laboratory Animal Science 
Associations (FELASA) on health monitoring in 
accordance with the regulations of the Association for 
Research in Vision and Ophthalmology. Animals were 
killed by cervical dislocation and eyes were enucleated. 
The lens, anterior segment, vitreous body, retinal pigment 
epithelium and sclera were removed.  
2.4. Retinal explants 
Ex vivo assays were performed with retinas from 8 
weeks old male db/+ and db/db mice as previously 
described (22). Following isolation, retinas were cultured 
in R16 medium (provided by Dr. P.A. Ekstrom, Lund 
University, Sweden) with no additional serum. Retinas 
were stimulated with R-DS-ONJ (compound C5) at 50 µM 
for 24 h as indicated in the figure legends.  
2.5. Analysis of cellular viability 
Bv-2 cells were seeded in 24-well plates and allowed to 
stabilize overnight. The cells were then treated with R-DS-
ONJ (1-50 µM) for 24 h. Following incubation, the 
viability of the cells was measured with crystal violet as 
described (23).  
2.6. Analysis of Nitrites (NO2-) 
Levels of NO2- were measured using the Griess method 
(24). In an acidic solution with 1 % sulphanilamide and 0.1 
% N-(1-Naphthyl) ethylenediamine (NEDA), nitrites 
convert into a pink compound that is colorimetric 
calculated at 540 nm in a microplate reader (Versamax 
Tunable Microplate reader, Molecular Devices, 
Sunnyvaley, CA, EEUU). 
2.7. Western blot 
Whole retinas or Bv-2 cells were homogenized in lysis 
buffer containing 50 mM Tris-HCl, 1 % Triton X-100, 2 
mM EGTA, 10 mM EDTA acid, 100 mM NaF, 1 mM 
Na4P2O7, 2 mM Na3VO4, 100 µg/mL 
phenylmethylsulphonyl fluoride, 1 µg/mL aprotinin, and 1 
µg/mL leupeptin, supplemented with protease inhibitors 
(10 µg/ml leupeptin, 10 µg/ml aprotinin, and 100 µg/ml 
phenylmethylsulphonyl fluoride). All debris was removed 
by centrifugation at 14,000 x g for 10 min at 4ºC and 
protein concentration was quantified using the Bio-Rad 
protein assay with BSA as a standard. Equivalent amounts 
of protein were resolved using denaturing sodium dodecyl 
sulphate-polyacrilamide gel electrophoresis (SDS-PAGE), 
followed by transfer to PVDF membranes (Bio-Rad). 
Membranes were blocked using 5 % non-fat dried milk or 
3 % BSA in 10 mM Tris-HCl, 150 mM NaCl, pH 7.5 
(TBS), and incubated overnight with several antibodies 
(1:2000 unless otherwise stated) in 0.05 % Tween-20-
TBS. Immunoreactive bands were visualized using the 
enhanced chemioluminiscence reagent (Bio-Rad). 
Antibodies against iNOS (sc- 650), IκBα (sc-371), NFkB 
p65(C-20) (sc-372), JNK (sc-571), phospho-38 MAPK 
(Thr180/Tyr182) (sc-17852-R) and p38 MAPK (sc-9212) 
were purchased from Santa Cruz Biotechnology (Palo 
Alto, CA, USA). Anti-phospho-JNK (Thr183/Tyr185) 
(#4668) antibody was purchased from Cell Signaling 
Technology (MA, USA). Anti-Arginase-1 (BD 610708) 
was purchased from BD Biosciences (Madrid, Spain). 
Anti-α-tubulin (T-5168) antibody was from Sigma 
Chemical Co. (St Louis, MO, USA). 
2.8. Immunofluorescence 
Eyes, retinal explants or Bv-2 cells were fixed in 4 % 
paraformaldehyde for 24 h at 4°C and infiltrated with 
sucrose 25 % (w/v). For immunofluorescence analysis, we 
followed the protocol previously detailed (25). The 
samples were then incubated overnight in a humid 
chamber at 4 ºC with rabbit anti-GFAP (glial fibrillary 
acidic protein) (1:1000), mouse anti-arginase-1 (1:1000) 
and rabbit anti-iNOS (1:1000) antibodies in blocking 
solution. Samples were washed and incubated for 90 min 
with anti-rabbit, anti-mouse, anti-goat or anti-rat 
!
Ana I. Arroba, Ángela M. Valverde 
@Real Academia Nacional de Farmacia. Spain 84 
immunoglobulin antibodies conjugated to Alexa 647 or 
488 (1:2000; Molecular Probes, Eugene, OR). After 
washing, sections were mounted with medium 
(Fluoromount G) containing 4-6-diamidino-2-phenylindole 
(DAPI). Staining was observed with an inverted laser 
confocal microscope LSM710 (Carl Zeiss Microscopy 
GmbH, Göttingen, Germany).After washing, sections were 
mounted with medium (Fluoromount G) containing 4-6-
diamidino-2-phenylindole (DAPI). Staining was observed 
with an inverted laser confocal microscope LSM710 (Carl 
Zeiss Microscopy GmbH, Göttingen, Germany).  
2.9. Endotoxin detection 
Serum endotoxin concentrations were measured with a 
commercial kit (QAYEE-BIO; Deltaclon, Madrid, Spain) 
according to the manufacturer’s instructions. Briefly, 
blood samples were collected in non-pyrogenic and 
endotoxin-free tubes, centrifuged at 2,500 x g for 10 min 
and serum was separated. Samples were diluted (1/5) with 
endotoxin-free water and horseradish peroxidase (HRP) 
was added. Samples were gently shacked, incubated for 60 
min at 37°C and then washed 5 times. Chromogen solution 
A was added to the samples that were gently shacked and 
further incubated for 10 min at 37ºC protected from light. 
Finally, stop solution was added and samples were 
measured at 450 nm. 
2.10. Quantitative real-time PCR (qRT-PCR) 
Total RNA was extracted with Trizol® reagent 
(Invitrogen, Madrid, Spain) and reverse transcribed using a 
SuperScript™ III First-Strand Synthesis System for RT-
qPCR following the manufacturer’s indications 
(Invitrogen). RT-qPCR was performed with an ABI 7900 
sequence detector. Primer-probe sets for mouse TNFα, 
IL6, IL1β, iNOS, arginase-1 and 18s were purchased as 
predesigned TaqMan gene expression assays (Applied 
Biosystems, Spain). 
2.11. Statistical analysis 
Densitometry of the Western blots was performed 
using the Image J program. Values in all graphs 
represented the mean ± SEM. Statistical tests were 
performed using SPSS 21.0 for Windows (SPSS Inc. IBM, 
Armonk, NY, USA). Data were analyzed by one-way 
ANOVA followed by Bonferroni t-test or by paired t-test 
when comparisons were among two groups. Differences 
were considered significant at *p≤ 0.05. 
3. RESULTS 
3.1. LPS-treated Bv-2 cells induced a pro-inflammatory 
response that was reduced by co-treatment with M2 
cytokines or the sp2-iminosugar derivative R-DS-ONJ  
We stimulated Bv-2 cells, a mouse microglia cell line, 
with LPS (M1 stimulus) in the absence or presence of M2 
cytokines (IL4/IL13). LPS was used as a pro-inflammatory 
stimulus since it induces an environment similar to that 
found in the obesity-related diabetic context (26). Based 
on that, Bv-2 cells were cultured in the presence of LPS, 
IL4/IL13 (M2) and the combination of both (LPS+M2). 
Figure 2A shows that the release of nitrites in the culture 
medium in LPS-treated Bv-2 cells was significantly 
reduced by the co-treatment with IL4/IL13. Likewise, 
iNOS, which was elevated in LPS-treated Bv-2 cells, 
significantly decreased by the co-treatment with M2 
cytokines (Figure 2B). Conversely, arginase-1 decreased 
by LPS treatment, this effect being ameliorated in the 
combination of LPS plus IL4/IL13. The effect of M2 
cytokines was also evident by the decrease of LPS-induced 
mRNA levels of TNFα, IL1β, IL6 and iNOS (Figure 2C). 
We tested a pharmacological approach using the sp2-
iminosugar dodecylsulfoxide derivative R-DS-ONJ 
(referred as C5; Figure 3A). As shown in Figure 3B, the 
viability of Bv-2 cells exposed to R-DS-ONJ (50 µM) was 
not affected. In Bv-2 cells cultured with LPS plus R-DS-
ONJ, nitrite production and iNOS expression (mRNA and 
protein) were reduced as compared to the LPS condition 
(Figure 3C, 3D, 3E). R-DS-ONJ also decreased mRNA 
levels of the pro-inflammatory cytokines IL1β and IL6 
(Figure 3E). 
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Figure 2. IL4/IL13 (M2 cytokines) prevented the pro-inflammatory effects of LPS in Bv-2 microglia cells. Bv-2 cells were treated 
with LPS (200 ng/ml) in the absence or presence of IL4/IL13 (20 ng/ml each). A) Nitrites in the culture medium. B) Western blot for 
arginase-1 and iNOS. C) mRNA levels of TNFα, IL1β, IL6 and iNOS. Results are expressed as 2-ΔCt. Results are means ± SEM (n=5 
independent experiments); *p≤0.05 LPS+M2 vs LPS. 
 
 
 
Figure 3. Sp2-iminosugar dodecylsulfoxide R-DS-ONJ (compound 5) prevented LPS-mediated effects in Bv-2 microglia cells and 
increased arginase-1 in retinal explants. Bv-2 cells were treated with LPS (200 ng/ml) in the absence or presence of (1R)-1-
dodecylsulfinyl-5N,6O-oxomethylidenenojirimycin (R-DS-ONJ, referred as C5 in the figures) at the indicated doses. A) Chemical 
structure of C5 compound. B) Crystal violet staining. C) Nitrites accumulation. D) Western blot for iNOS using α-Tubulin as a loading 
control. E) mRNA levels of TNFα, IL1β, IL6 and iNOS. Results are expressed as 2-ΔCt. Results are means ± SEM (n=5 independent 
experiments); *p≤0.05 LPS+R-DS-ONJ vs LPS. 
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3.2. M2 cytokines or sp2-iminosugar derivative R-DS-ONJ 
decreased the pro-inflammatory signaling pathways 
induced by LPS in Bv-2 cells 
We also evaluated the impact of M2 cytokines or R-
DS-ONJ in the early pro-inflammatory signaling pathways 
activated by LPS in Bv-2 cells. As Figure 4 shows, co-
treatment with M2 cytokines prevented LPS-mediated 
IκBα degradation, the phosphorylation of JNK, but this 
effect was less evident in the phosphorylation of p38 
MAPK. 
 
 
Figure 4. M2 cytokines decreased the pro-inflammatory signaling pathways induced by LPS in Bv-2 cells. Bv-2 cells were treated 
with LPS (200 ng/ml) in the absence or presence of IL4/IL13 (20 ng/ml each) for the indicated time-periods. Protein extracts (30 µg) were 
separated by SDS-PAGE and analyzed by Western blot with antibodies against phospho-JNK, total JNK, phospho-p38 MAPK, total p38 
MAPK and IκBα. α-tubulin was used as a loading control. Representative autoradiograms are shown (n=6 independent experiments). The 
blots were quantitated by scanning densitometry. The results are means ± SEM. Data were analyzed by one-way ANOVA followed by 
Bonferroni t-test; *p≤ 0.05 LPS+M2 vs LPS.  
The effect of R-DS-ONJ on the early proinflammatory 
signaling pathway induced by LPS in Bv-2 cells was also 
analyzed. Co-treatment with R-DS-ONJ prevented LPS-
mediated IκBα degradation, the phosphorylation of JNK 
and p38 MAPK (Figure 5A). As Figure 5B shows, the 
treatment with R-DS-ONJ in presence of LPS prevents 
from NFkB p65 translocation to the nucleus. 
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Figure 5. R-DS-ONJ decreased the pro-inflammatory signaling pathways induced by LPS in Bv-2 cells. Bv-2 cells were treated with 
LPS (200 ng/ml) in the absence or presence of R-DS-ONJ (50 µM) for the indicated time-periods. A) Protein extracts (30 µg) were 
separated by SDS-PAGE and analyzed by Western blot with antibodies against phospho-JNK, total JNK, phospho-p38 MAPK, total p38 
MAPK and IκBα. α-Tubulin was used as a loading control. Representative autoradiograms are shown (n=6 independent experiments). 
The blots were quantities by scanning densitometry. The results are means ± SEM. Data were analyzed by one-way ANOVA followed by 
Bonferroni t-test; *p≤ 0.05 LPS+R-DS-ONJ vs LPS. B) Bv-2 cells treated for 60 min with LPS in the absence or presence of R-DS-ONJ 
were immunostained for p65 NFκB (green) and counterstained with DAPI (blue). Representative images are shown.  
3.3. Sp2-iminosugar derived R-DS-ONJ prevented gliosis 
and M1 status associated to inflammation in retinas from 
db/db mice during DR 
In order to determine the appropriate time-period in 
which to analyze the effect of Sp2-iminosugar derived R-
DS-ONJ in retinal explants of db/db mice, we first study 
several parameters related to inflammation in circulation 
and in the retina in this mouse model. 
During obesity, increased intestinal permeability leads 
to the leakage of bacterial products into the circulation that 
exacerbates the pro-inflammatory responses (27). Higher 
levels of serum endotoxin were detected in db/db mice at 5 
weeks compared to age-matched db/+ controls (Figure 
6A) and these differences were maintained up to 20 weeks. 
Next, we evaluated the impact of the circulating 
endotoxemia on the inflammatory markers in the retina. 
Whereas in the retina of db/db mice iNOS mRNA and 
protein levels peaked at 5 weeks and remained elevated up 
to 8 weeks in comparison to age-matched db/+ controls, 
arginase-1 mRNA and protein levels increased at 5-6 
weeks and returned to basal levels at 8 weeks. These data 
reflect the decrease in the anti-inflammatory profile of the 
retina in db/db mice during DR progression (Figure 6B). 
The immunofluorescence analysis in retinal sections 
revealed iNOS specific immunostaining (green) in OS 
(outer segment), OPL (outer plexiform layer), INL (inner 
nuclear layer) and GCL (ganglion cell layer) at 5 and 8 
weeks in db/db mice, being immunolabelling stronger at 8 
A 
B 
Ana I. Arroba, Ángela M. Valverde 
@Real Academia Nacional de Farmacia. Spain 88 
weeks (Figure 6C). 
 
 
 
Figure 6. Circulating endotoxemia and pro-inflammatory cytokines during DR progression in db/db mice. A) Serum endotoxin in 
db/db and db/+ mice at different ages. Results are means ± SEM (n=5 retinas per condition). *p≤0.05 db/db vs db/+ matched at each age. 
B) (left panel) M1 (iNOS) and M2 (arginase-1) mRNAs in db/db and db/+ mice at 5, 8 and 20 weeks. Results are expressed as 2-ΔCt. 
(right panel) iNOS and arginase-1 protein levels in retinas from db/db and db/+ mice analyzed by Western blot at the ages indicated. 
Results are means ± SEM (n=5 retinas per condition). *p≤0.05 db/db vs db/+ matched at each age. C) iNOS immunostaining (green) 
counterstained with DAPI (blue) (n=5 retinas per condition). Retinal layers are labelled as ONL (outer nuclear layer), OPL (outer 
plexiform layer), INL (inner nuclear layer), (IPL) inner plexiform layer and GCL (ganglion cell layer). At least 3 retinas and 4 non-
adjacent sections per retina were analyzed for each experimental condition. 
B 
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Based on these analysis of the inflammatory profile of 
the retina in db/db mice during DR progression, we 
performed the ex vivo analysis in retinal explants at 8 
weeks of age. Retinal explants from 8 weeks old db/+ and 
db/db mice treated for 24 h with R-DS-ONJ showed 
increased arginase-1 expression (M2 marker) compared to 
their respective untreated retinas (Figure 7A). Moreover, 
reactive gliosis, which was already present in retinas from 
db/db mice at 8 weeks (28) was maintained in retinal 
explants and decreased by the treatment with R-DS-ONJ 
(Figure 7B).  
 
 
Figure 7. Retinal gliosis is detected in 8 weeks-old db/db mice. Retinal explants from 8 weeks old db/+ and db/db mice were treated for 
24 h with R-DS-ONJ. A) Western blot for arginase-1 (n=5 retinas per condition) G) Representative immunostaining for GFAP in whole 
retina. 
4. DISCUSSION 
T2D is considered a chronic low-grade systemic 
inflammatory disease characterized by changes in both the 
secretion of cytokines and the polarization of tissue-
resident macrophages towards a M1 state (29-31) as 
demonstrated by the increased plasma levels of pro-
inflammatory cytokines and C-reactive protein found in 
diabetic patients (32, 33). Among diabetic complications, 
DR is a multifactorial disease in which hyperglycaemia, 
inflammation and neuronal dysfunction are major factors 
involved in its etiopathology (34).  
db/db mice recapitulate human DR progression and, 
therefore, these mice have been extensively used to study 
relevant processes such as retinal vascular leakage and 
neurodegeneration, as well to test potential 
pharmacological approaches (20, 35). Herein we have used 
for the first time db/db mice to characterize the microglia 
polarization during DR in a systemic pro-inflammatory 
environment. Notably, at 5 weeks of age, systemic 
endotoxemia was detected in db/db mice, probably 
reflecting alterations in intestinal barrier permeability and 
gut microbiota at this early period (36, 37). Although 
circulating TNFα and IL6 are elevated in 5 weeks old 
db/db mice (results not shown), the local inflammation in 
the retina was not manifested at this age since mRNA 
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levels of pro-inflammatory cytokines remained similar as 
in age-matched db+ lean mice. However, the analysis of 
M1/M2 markers in total retina revealed the coexistence of 
elevated iNOS (M1) and arginase-1 (M2) mRNA and 
protein levels only at an early stage of DR (5 weeks), both 
markers being localized mainly in the IPL, OPL and GCL 
where microglia was immunodetected. By contrast, in 
retinas of db/db mice at 8 weeks both the decrease in 
arginase-1 and the maintenance of high expression of 
iNOS paralleled the IL6 and TNFα mRNA levels. Taken 
together, these data indicate that in the retina of db/db 
mice the loss of the anti-inflammatory defense correlated 
with deterioration of the visual function in an age-
dependent manner (20). Importantly, in retinas from db/db 
mice at 8 weeks treatment with R-DS-ONJ reduced GFAP 
immunostaining and also increased arginase-1, reflecting a 
regression towards an early stage of DR. 
This study also provides new mechanistic insights in an in 
vitro bioassay that mimics the pro-inflammatory context of 
DR. We have used LPS as a pro-inflammatory stimulus in 
Bv-2 mouse microglia cell line since the M1 response of 
these cells resembles the in vivo situation in db/db mice in 
the course of DR. In Bv-2 microglial cells treated with 
LPS, the co-treatment with IL4/IL3 (M2 cytokines) or the 
sp2-iminosugar dodecylsulfoxide R-DS-ONJ ameliorated 
the M1 phenotype induced by endotoxemia, as reflected by 
decreases in iNOS, nitrites and reduction of 
expression/secretion of pro-inflammatory cytokines. At the 
molecular level, treatment with M2 cytokines or R-DS-
ONJ decreased the early activation of stress kinases (JNK 
and p38 MAPK) (38), prevented IκBα degradation and 
nuclear translocation of NF-κB. 
5. CONCLUSION 
Our results have shown for the first time the dynamics 
of microglia polarization during DR evolution in db/db 
mice and strongly suggest that targeting 
neuroinflammation by switching microglia towards a M2 
polarization state might be a therapeutic strategy to delay 
and/or prevent the deterioration of visual function in 
diabetic patients. 
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